How to Choose a PRP Injection Specialist: What Patients Need to Know
- Mar 3
- 7 min read
Written by Dr. Jeffrey Peng, MD — Board-Certified Sports Medicine Physician
Published: March 3, 2025 | Last Updated: March 3, 2025
Selecting the right physician for your platelet-rich plasma injection is one of the most consequential decisions you can make about your treatment. In my practice, I consistently see patients who have had suboptimal outcomes not because PRP failed them, but because the procedure was performed incorrectly — wrong technique, insufficient platelet dose, or a provider without the specialized training needed to deliver meaningful results. The guidance below will help you identify a qualified specialist and avoid the pitfalls that too often derail this otherwise promising therapy.
Watch the Full Video
Why Imaging Guidance Is Non-Negotiable for PRP Injections
The single most important technical requirement for any PRP injection is imaging guidance — specifically, real-time ultrasound. Regardless of how many years of experience a provider has, even highly skilled orthopedic clinicians miss their target without it. Landmark-based injections, where the physician estimates the target anatomy by feel alone, are simply not accurate enough for this level of precision medicine.
A comprehensive review published in the Orthopaedic Journal of Sports Medicine demonstrated the accuracy gap clearly: landmark-based techniques for common injection sites routinely achieve accuracies in the low-to-mid 60% range, while ultrasound-guided injections approach or achieve near-perfect accuracy across virtually every anatomic location. For the glenohumeral joint, accuracy improves from 72% to 92%; for the hip, from 67–78% to 97–100%; for foot and ankle injections, ultrasound guidance achieves 100% accuracy compared to 58–100% with landmark technique alone (Daniels et al., 2018).
Imaging guidance is especially critical when targeting soft tissue pathology such as partial tendon tears. No provider can palpate the precise location of a partial rotator cuff tear and reliably guide a needle into it without ultrasound visualization — the anatomy simply does not allow it.
A randomized, controlled, double-blind clinical trial published in Biomedicines evaluated ultrasound-guided tendon debridement followed by either PRP or saline placebo. At six months, 87% of the PRP group experienced a reduction in tear size, with 79% achieving complete healing. In contrast, only 32% of the saline group had tears decrease in size, and full healing occurred in just 21% (de Castro et al., 2023).
These outcomes are not achievable with landmark-based technique. Before scheduling any PRP procedure, confirm with your provider that ultrasound guidance will be used throughout the injection. If you encounter resistance to this request, I would encourage you to seek a provider with the technical skills to do the job correctly.
Platelet Dosing: Why the Amount Injected Determines Your Outcome
Like any medication in medicine, PRP follows a dose-response relationship — higher doses produce better outcomes. This principle has now moved from theoretical to clinically proven.
A prospective, triple-blind randomized clinical trial published in the Orthopaedic Journal of Sports Medicine directly compared conventional-dose PRP (approximately 2.8 billion platelets) against a superdose (approximately 5.6 billion platelets) for early knee osteoarthritis. At both three and six months, the higher-dose group demonstrated significantly better improvements in pain scores and functional outcomes. Patient satisfaction at six months reached 96% in the superdose group compared to 68% in the conventional-dose group (Patel et al., 2024).
This is further supported by a systematic review and meta-analysis published in Arthroscopy that analyzed 29 randomized controlled trials of PRP for knee osteoarthritis. Studies reporting statistically significant positive outcomes used a mean platelet dose of approximately 5.5 billion platelets, while studies that found no benefit used a mean dose of approximately 2.3 billion platelets — a difference that was highly statistically significant (Berrigan et al., 2024).
Platelet dose is directly tied to how much blood is drawn and how much that blood the PRP processing kit can handle. Most standard commercial kits process only 10–20 mL of blood, yielding a very low platelet count. Based on current evidence and my clinical experience, here is what I recommend asking your provider:
For soft tissue injections — tendons and ligaments — approximately 5 billion platelets are typically needed, which requires around a 30 mL blood draw. For large joint injections such as knee and hip arthritis, a target of approximately 10 billion platelets is appropriate, requiring roughly a 60 mL draw. Ask your provider specifically how much blood will be drawn and what volume their kit is designed to process. If those numbers don't align with the above thresholds, the platelet dose will likely be insufficient.
How to Evaluate Provider Credentials and Training
Not all providers offering PRP injections have equivalent training. The rise of "regenerative medicine" clinics has created a market where mid-level practitioners — physician assistants, nurse practitioners, chiropractors, and naturopaths — are routinely performing PRP procedures without the depth of medical and musculoskeletal training these procedures require. While there are exceptional practitioners at every level, the procedural complexity, potential complications, and importance of patient selection demand a higher standard of oversight.
I recommend seeking out an MD or DO who is board-certified in sports medicine or who has completed specialty fellowship training directly relevant to musculoskeletal medicine. Sports medicine-trained physicians have concentrated education in orthobiologics, procedural technique, diagnostic ultrasound, and current clinical literature — all of which directly affect your outcome.
An academic affiliation is a useful secondary indicator. Physicians who serve on residency or fellowship faculty are incentivized to remain current with emerging evidence because they are actively teaching it. This is not a universal rule, but it correlates with providers who are more likely to be performing evidence-based procedures rather than simply marketing treatments.
Be cautious about arrangements where a general practitioner has been hired by a chiropractic, physical therapy, or naturopathic clinic to perform PRP injections. Many of these physicians lack the procedural training and clinical context to deliver optimal outcomes. The motivation in these arrangements is frequently financial rather than patient-centered.
Red Flags to Watch for When Choosing a PRP Provider
Beyond credentials, the quality of a consultation itself tells you a great deal about whether a provider is the right fit. Here are the key warning signs I counsel patients to watch for:
Inadequate education and counseling. If your provider does not take the time to explain the procedure, expected outcomes, and recovery timeline in detail, that is a significant red flag. You should leave the consultation with a clear understanding of what will happen, when you can expect improvement, and what the research actually shows.
Pressure to proceed without alternatives. A reputable physician will discuss the full spectrum of treatment options — conservative measures, other injections, physical therapy — before recommending PRP. If you feel pushed toward a procedure without adequate exploration of alternatives, treat that as a warning.
Rushed appointments. Thorough evaluation takes time. A provider who does not review your full medical history, imaging, and prior treatment course before recommending PRP is not investing appropriately in your care.
Inability to describe expected outcomes. Experienced PRP providers can walk patients through realistic week-by-week expectations based on clinical trial data. If your physician cannot articulate what recovery typically looks like or defaults to anecdotal success stories rather than citing randomized controlled trials, that reflects limited procedural experience.
Difficulty reaching the provider before or after treatment. Questions and concerns arise throughout recovery, and access to your physician is part of the care. Avoid providers who are consistently difficult to contact or who do not maintain clear post-procedure communication protocols.
Unsubstantiated claims on their website or in consultation. If a provider is citing cure rates or success statistics that are not grounded in peer-reviewed literature, or making claims that dramatically exceed what the published evidence supports, be skeptical.
A Note on Medical Tourism and Overseas Regenerative Treatments
Overseas regenerative medicine clinics — particularly those offering stem cell infusions in Mexico, Panama, and other countries — have become increasingly visible on social media and patient forums. The appeal is understandable: lower costs and dramatic testimonials make these options seem attractive. In practice, however, I have seen significant harm result from these unregulated treatments.
I treated a patient who traveled abroad for an IV stem cell infusion followed by injections throughout the spine, hips, and knees. He developed a post-procedural knee infection, was told by his treating provider that it was unrelated to the procedure, and was subsequently unable to reach anyone from the clinic for guidance. On return to the United States, he required IV antibiotics and a prolonged recovery — and remained worse off than before treatment.
It is also worth understanding that many of the enthusiastic post-treatment testimonials from these clinics reflect the effects of IV dexamethasone — a potent corticosteroid frequently co-administered with stem cells — rather than any regenerative response. The temporary anti-inflammatory effect can be dramatic but dissipates within days of returning home. The underlying condition remains untreated.
The absence of regulatory oversight, meaningful informed consent processes, and post-procedure follow-up care creates substantial risk. I encourage patients to weigh these factors seriously before pursuing treatment abroad.
References
1. Daniels EW, Cole D, Jacobs B, Phillips SF. Existing Evidence on Ultrasound-Guided Injections in Sports Medicine. Orthop J Sports Med. 2018;6(2). DOI: 10.1177/2325967118756576
2. de Castro RLB, Antonio BP, Giovannetti GA, Annichino-Bizzacchi JM. Total Healing of a Partial Rupture of the Supraspinatus Tendon Using Barbotage Technique Associated with Platelet-Rich Plasma: A Randomized, Controlled, and Double-Blind Clinical Trial. Biomedicines. 2023;11(7). DOI: 10.3390/biomedicines11071849
3. Patel S, Gahlaut S, Thami T, Chouhan DK, Jain A, Dhillon MS. Comparison of Conventional Dose Versus Superdose Platelet-Rich Plasma for Knee Osteoarthritis: A Prospective, Triple-Blind, Randomized Clinical Trial. Orthop J Sports Med. 2024;12(2). DOI: 10.1177/23259671241227863
4. Berrigan WA, Bailowitz Z, Park A, Reddy A, Liu R, Lansdown D. A Greater Platelet Dose May Yield Better Clinical Outcomes for Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Systematic Review. Arthroscopy. 2024;41(3):809-817. DOI: 10.1016/j.arthro.2024.03.018
Disclaimer: This content is intended for educational purposes only and does not constitute medical advice. The information provided does not substitute for the advice, diagnosis, or treatment of a qualified physician. Always consult your healthcare provider with questions regarding your health or a medical condition.
Comments